Philadelphia, Pennsylvania, United States
5K followers 500+ connections

Join to view profile

Activity

Join now to see all activity

Experience & Education

  • Drexel University School of Biomedical Engineering, Science and Health Systems

View Joel S.’s full experience

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Licenses & Certifications

Publications

  • reproducibility of in-vivo oct measured three-dimensional human lamina cribrosa microarchitecture

    plos one

    abstract purpose to determine the reproducibility of automated segmentation of the three-dimensional (3d) lamina cribrosa (lc) microarchitecture scanned in-vivo using optical coherence tomography (oct). methods thirty-nine eyes (8 healthy, 19 glaucoma suspects and 12 glaucoma) from 49 subjects were scanned twice using swept-source (ss−) oct in a 3.5×3.5×3.64 mm (400×400×896 pixels) volume centered on the optic nerve head, with the focus readjusted after each scan. the lc was automatically…

    abstract purpose to determine the reproducibility of automated segmentation of the three-dimensional (3d) lamina cribrosa (lc) microarchitecture scanned in-vivo using optical coherence tomography (oct). methods thirty-nine eyes (8 healthy, 19 glaucoma suspects and 12 glaucoma) from 49 subjects were scanned twice using swept-source (ss−) oct in a 3.5×3.5×3.64 mm (400×400×896 pixels) volume centered on the optic nerve head, with the focus readjusted after each scan. the lc was automatically segmented and analyzed for microarchitectural parameters, including pore diameter, pore diameter standard deviation (sd), pore aspect ratio, pore area, beam thickness, beam thickness sd, and beam thickness to pore diameter ratio. reproducibility of the parameters was assessed by computing the imprecision of the parameters between the scans. results the automated segmentation demonstrated excellent reproducibility. all lc microarchitecture parameters had an imprecision of less or equal to 4.2%. there was little variability in imprecision with respect to diagnostic category, although the method tends to show higher imprecision amongst healthy subjects. conclusion the proposed automated segmentation of the lc demonstrated high reproducibility for 3d lc parameters. this segmentation analysis tool will be useful for in-vivo studies of the lc.

    See publication
  • Inflammatory response to intravitreal injection of gold nanorods

    British Journal of Ophthalmology

    Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
    Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets…

    Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
    Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets (T cells, myeloid cells, macrophages, neutrophils). Generalised estimation equations were used to compare cell counts between groups.
    Results: PSS-AuNRs and Ab-AuNRs were visualised in the vitreous 30 min and 24 h post-injection with OCT. At 24 h, a statistically significant increase in leukocytes, comprised primarily of neutrophils, was observed in eyes that received either AuNR in comparison to eyes that received saline. The accumulation of leukocytes was equal in eyes given PSS-AuNR or Ab-AuNR. Endotoxin-resistant C3H/HeJ mice also showed ocular inflammation after injection with AuNRs, indicating that the inflammatory response was not due to lipopolysaccharide contamination of AuNRs.
    Conclusions: Although AuNRs can be visualised in the eye using OCT, they can induce ocular inflammation, which limits their use as a contrast agent.

    Other authors
    See publication
  • Inflammatory response to intravitreal injection of gold nanorods

    British Journal of Ophthalmology

    Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
    Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets…

    Aim: To evaluate the utility of gold nanorods (AuNRs) as a contrast agent for ocular optical coherence tomography (OCT).
    Methods: Mice were intravitreally injected with sterile AuNRs coated with either poly(strenesulfate) (PSS-AuNRs) or anti-CD90.2 antibodies (Ab-AuNRs), and imaged using OCT. After 24 h, eyes were processed for transmission electron microscopy or rendered into single cell suspensions for flow cytometric analysis to determine absolute numbers of CD45+ leukocytes and subsets (T cells, myeloid cells, macrophages, neutrophils). Generalised estimation equations were used to compare cell counts between groups.
    Results: PSS-AuNRs and Ab-AuNRs were visualised in the vitreous 30 min and 24 h post-injection with OCT. At 24 h, a statistically significant increase in leukocytes, comprised primarily of neutrophils, was observed in eyes that received either AuNR in comparison to eyes that received saline. The accumulation of leukocytes was equal in eyes given PSS-AuNR or Ab-AuNR. Endotoxin-resistant C3H/HeJ mice also showed ocular inflammation after injection with AuNRs, indicating that the inflammatory response was not due to lipopolysaccharide contamination of AuNRs.
    Conclusions: Although AuNRs can be visualised in the eye using OCT, they can induce ocular inflammation, which limits their use as a contrast agent.

    Other authors
    See publication
  • Optical coherence tomography: future trends for imaging in glaucoma

    Optom Vis Sci

    Optical coherence tomography captures a major role in clinical assessment in eye care. Innovative hardware and software improvements in the technology would further enhance its usefulness. In this review, we present several promising initiatives currently in development or early phase of assessment that we expect to have a future impact on optical coherence tomography.

    Other authors
    See publication
  • Variation in optical coherence tomography signal quality as an indicator of retinal nerve fibre layer segmentation error

    Br J Ophthalmol

    Commercial optical coherence tomography (OCT) systems use global signal quality indices to quantify scan quality. Signal quality can vary throughout a scan, contributing to local retinal nerve fibre layer segmentation errors (SegE). The purpose of this study was to develop an automated method, using local scan quality, to predict SegE.

    Other authors
    See publication
  • Clinical application of MRI in ophthalmology.

    NMR Biomed.

    MRI has long been applied to clinical medical and neurological cases for the structural assessment of tissues as well as their physiological and functional needs and processes. These uses are at a variety of developmental stages in ophthalmology, from common use of clinical structural assessment for neuro-ophthalmology and evaluation of space-occupying lesions to the beginning stages of experimentally measuring functional activation of specific layers within the retina and measurement of…

    MRI has long been applied to clinical medical and neurological cases for the structural assessment of tissues as well as their physiological and functional needs and processes. These uses are at a variety of developmental stages in ophthalmology, from common use of clinical structural assessment for neuro-ophthalmology and evaluation of space-occupying lesions to the beginning stages of experimentally measuring functional activation of specific layers within the retina and measurement of physiological oxygen responses. New MRI methodologies, such as the use of orbital coils and Gd-DTPA image enhancement, have been researched, developed, and validated in the eye, opening new possibilities for this technology to enter the clinic. This review aims to summarize the clinical ophthalmological uses of MRI, focusing on the current use of the technology and future applications.

    Other authors
    See publication
  • Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty.

    -

    Other authors
  • Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty.

    -

    Other authors

Patents

  • Inhibition of proliferation and fibrotic response of activated corneal stromal cells

    Issued USPTO 08815946

    Provided herein are methods of preventing a fibrotic response and/or scarring in a wound, comprising administering to a subject a composition comprising an amount of an amide or ester of an alpha-ketoalkanoic acid effective to inhibit a proliferative and/or fibrotic response in the wound. In one instance, the wound is to a subject's cornea, such as a wound resulting from refractive surgery. In one embodiment, the amide or ester of an alpha-ketoalkanoic acid is ethyl pyruvate.

    See patent
  • Method of Using Matrix Metalloproteinase Inhibitors in Filtering Blebs Following Glaucoma Filtering Surgery and in the Treatment of Ischemic Damage to the Retina and Optic Nerve

    Issued US 6503892

    This invention provides a method of inhibiting, preventing, and/or treating conjunctival filtering bleb leaks that may occur following glaucoma filtering surgery by administering Matrix Metalloproteinase inhibitors to glaucoma patients who have undergone such surgery. The invention additionally includes a method of using Matrix Metalloproteinase inhibitors to inhibit, prevent, and/or treat ischemic damage to the retina and optic nerve in patients in need of such treatment.

    Other inventors

Projects

  • Hydrodynamic Properties of Glaucoma Drainage Implants In Vitro.

    -

    Other creators

Organizations

  • Drexel University School of Biomedical Engineering, Science and Health Systems

    Professor of Biomedical Engineering

    - Present
  • Wills Eye Hospital

    Kenneth L. Roper, MD Endowed Chair Vice Chair for Research Innovation Vickie and Jack Farber Vision Research Center Co-Director, Glaucoma Service Wills Eye Hospital Professor, Department of Ophthalmology Sidney Kimmel Medical College at Thomas Jefferson University

    - Present
  • NYU

    Professor and Chairman of Ophthalmology

    -

Recommendations received

More activity by Joel S.

View Joel S.’s full profile

  • See who you know in common
  • Get introduced
  • Contact Joel S. directly
Join to view full profile

Other similar profiles

Explore top content on LinkedIn

Find curated posts and insights for relevant topics all in one place.

View top content

Add new skills with these courses